The liver can regrow safely after tumor removal only when it is in good health. In this context, experts explain that about 20 percent of the organ is enough to fuel a full regenerative process, a point raised by the head of the drug therapy department at the National Center for Medical Research Oncology. Valery Breder, who leads the Interdisciplinary Association of Liver Tumor Specialists, emphasizes this capacity as a key factor in planning treatment strategies.
“But that 20 percent must be nourished by adequate blood flow, and the bile produced by the remaining tissue must be properly drained. There are many subtleties involved here,” Breder notes, highlighting the delicate balance required for successful regeneration and recovery after surgery.
He adds that tumor removal is not a universal option and ultimately depends on the patient’s overall condition. The decision hinges on multiple factors, including liver reserves and any accompanying health issues that could affect recovery.
“When we say a tumor is small, the question becomes whether it can be removed without compromising the liver’s ability to sustain life. The practical assessment relies on the functional reserves of the liver and the presence of other health problems. For example, an 80-year-old patient with limited mobility and several comorbidities may face a very different calculus than a younger individual with fewer health constraints,” the oncologist explains, illustrating how age and health status alter treatment choices.
Breder notes that in some cases, even a larger tumor can be excised along with a portion of the liver, leaving a remaining segment sufficient to sustain life. When this is feasible, surgery remains a viable option and often the best path forward for long-term outcomes.
“Of course, if surgery cannot be performed, other treatment avenues are always evaluated,” the specialist states, underscoring the need for a flexible, patient-centered approach that weighs benefits, risks, and the patient’s overall health trajectory.
Further information about how to recognize possible liver cancer indicators, the regional prevalence of the disease in Russia, and the liver’s influence on life expectancy are discussed in the Breeder report published on socialbites.ca. This report aims to provide a practical overview for readers seeking to understand liver cancer dynamics and the role of liver health in treatment decisions and prognosis.
The content also addresses common liver cancer symptoms that may precede a diagnosis, helping readers distinguish early signs from benign conditions and encouraging timely medical consultation for anyone noticing unusual changes in liver-related health or general well-being.